High affinity binding sites for 3(R)-hydroxyeicosatrienoic acid [12(R)- HETrE] in microvessel endothelial cells

Journal of Ocular Pharmacology and Therapeutics

Volumn 13, Issue 3, 1997, Pages 191-199

  Stoltz, Robert A ^a   Schwartzman, Michal Laniado ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; BINDING SITE; CHEMOTAXIS; CONFERENCE PAPER; CORNEA EPITHELIUM; CORNEA NEOVASCULARIZATION; ENDOTHELIUM CELL; INFLAMMATION; NONHUMAN; RABBIT; VASODILATATION;

EID: 0030961344     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1997.13.191     Document Type: Conference Paper

References (27)

1. Robertson, R.P. Characterization and regulation of prostaglandin and leukotriene receptors: An overview. Prostaglandins, 31:395-409, 1986.
2. Haas, T.A., Bastida, E., Nakamura, K., Hullin, F., Admirall, L. and Buchanan, M.R. Binding of 13-HODE and 5-, 12-, and 15-HETE to endothelial cells and subsequent platelet, neutrophil and tumor cell adhesion. Biochim. Biophys. Acta, 961:153-159, 1988.
3. Vonakis, B.M. and Vanderhoek, J.V. 15-Hydroxyeicosatetraenoic acid (15-HETE) receptors. J. Biol. Chem., 267:23625-23631, 1992.
4. Bito, L.Z. Prostaglandins, other eicosanoids, and their derivatives as potential antiglaucoma agents. In: Glaucoma: Applied pharmacology in medical treatment, Grune & Stratton, Inc., 1984, p. 477-505.
5. Negishi, N., Sugimoto, Y. and Ichikawa, A. Prostanoid receptors and their biological actions. Prog. Lipid Res., 32:417-434, 1993.
6. Masferrer, J.L. and Schwartzman, M.L. Novel cytochrome P450-dependent arachidonic acid metabolites and their ocular effects. In: The Ocular Effects of Prostaglandins and Other Eicosanoids, Bito, L.Z. and Stjernschantz, J., eds Alan R. Liss, New York, 1989, p. 85-93.
7. Laniado-Schwartzman, M., Lavrovsky, Y., Stoltz, R.A., Conners, M.S., Falck, J.R., Chauhan, K. and Abraham, N.G. Activation of nuclear factor kB and oncogene expression by 12(R)-hydroxyeicosatrienoic acid, an angiogenic factor in microvessel endothelial cells. J. Biol. Chem., 269:24321-24327, 1994.
8. Stoltz, R.A., Conners, M.S., Rapacon, M.M. and Schwartzman, M.L. 12(R)-Hydroxyeicosatrienoic acid (12(R)-HETrE) stereoselectively stimulates microvessel endothelial cell growth via high affinity binding sites. Invest. Ophthalmol. Vis. Sci., 35:1887, 1995.
9. Gerritsen, M.E., Carley, W. and Milici, A.J. Microvascular endothelial cells: Isolation, identification, and cultivation. Adv. Cell Cult., 6:35-67, 1988.
10. Davis, K.L. and Schwartzman, M.L. Endogenous formation of 12(R)hydroxy-5,8,14 eicosatrienoic acid: novel angiogenic cytochrome P450 metabolite. Invest. Ophthalmol. Vis. Sci., 30:333, 1989.
11. Murphy, R.C., Falck, J.R., Lumin, S., Yadagiri, P., Zirrolli, J.A., Balazy, M., Masferrer, J.L., Abraham, N.G. and Schwartzman, M.L. 12(R)-hydroxyeicosatetrienoic acid: a vasodilator cytochrome P450 dependent arachidonate metabolite from bovine corneal epithelium. J. Biol. Chem., 263:17197-17202, 1988.
12. Masferrer, J., Murphy, R.C., Pagano, P.J., Dunn, M.W. and Schwartzman, M.L. The ocular effects of a novel arachidonate metabolite formed by bovine corneal epithelium Invest. Ophthalmol. Vis. Sci., 30:454-460, 1989.
13. Conners, M.S., Stoltz, R.A., Webb, S.C., Rosenberg, J., Dunn, M.W., Abraham, N.G. and Schwartzman, M.L. A closed eye-contact lens model of corneal inflammation. I. Induction of cytochrome P450 arachidonic acid metabolism. Invest. Ophthalmol. Vis. Sci., 36:828-840, 1995.
14. Masferrer, J.L., Rimarachin, J.A., Gerritsen, M.E., Falck, J.R., Yadagiri, P., Dunn, M.W. and Schwartzman, M.L. 12(R)-hydroxyeicosatrienoic acid, a potent chemotactic and angiogenic factor produced by the cornea. Exp. Eye Res., 52:417-424, 1991.
15. Conners, M.S., Stoltz, R.A., Dunn, M.W., Levere, R.D., Abraham, N.G. and Schwartzman, M.L. A closed eye-contact lens model of corneal inflammation. H. Inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory sequelae. Invest. Ophthalmol. Vis. Sci., 36:841-850, 1995.
16. Ordway, R.W., Singer, J.J. and Walsh, J.V. Direct regulation of ion channels by fatty acids. Trends Neuroscience, 14:96-100, 1991.
17. Schafer, A.I., Takayama, H., Farrell, S. and Gimbrone, M.A. Incorporation of platelet and leukocyte lipoxygenase metabolites by cultured vascular cells. Blood, 67:373-378, 1986.
18. Pratt, W.B. Transformation of glucocorticoid and progesterone receptors to the DNA binding state. J. Cell Biol., 35:51-68, 1987.
19. Satoh, T., Cohen, H.T. and Katz, A.I. Intracellular signaling in the regulation of Na-K-ATPase: II. Role of eicosanoids. J. Clin. Invest., 91:409-415, 1993.
20. Harder, D.R., Gebremedhin, D., Narayanan, J., Jefcote, C., Falck, J.R., Campbell W.B. and Roman, R. Formation and action of a P450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am. J. Physiol., 266:H2098-H2107, 1994.
21. Vonakis, B.M. and Vanderhoek, J.Y. Simultaneous determination of hydroxyeicosanoid (HETE) binding to cells and its cellular metabolism. J. Lipid Res., 34:853-858, 1993.
22. Rabier, M., Crastes de Paulet, A. and Damon, M. Evidence for specific binding of 15-hydroxyeicosatetraenoic acid to pituitary cells. Biochem. Biophys. Res. Commun., 152:1179-1184, 1988.
23. Gross, E., Ruzicka, T., von Restorff, B., Stolz, W. and Klotz, K.N. High-affinity binding and lack of growth-promoting activity of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) in a human epidermal cell line. J. Invest. Dermatol., 94:446-451, 1990.
24. Arenberger, P., Kemeny, L., Rupee, R., Bieber, T. and Ruzicka, T. Langerhans cell of the skin possess high affinity 12(S)-hydroxyeicosatetraenoic acid receptors. Eur. J. Immunol. 22:2469-2472, 1992.
25. Herbertsson, H. and Hammarström, S. High-affinity binding sites for 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(S)-HETE) in carcinoma cells. FEBS Letters, 298:249-252, 1992
26. Halushka, P.V., Mais, D.E., Mayeux, P.R. and Morinelli, T.A. Thromboxane, prostaglandin and leukotriene receptors. Annu. Rev. Pharmacol. Toxicol., 29:213-239, 1989.
27. Spector, A.A., Gordon, J.A. and Moore, S.A. Hydroxyeicosatetraenoic acids (HETEs). Prog. Lipid. Res., 27:271-323, 1988.